Literature DB >> 18642293

Molecular signatures of metastasis in head and neck cancer.

Stefano Colella1, Kristy L Richards, Linda L Bachinski, Keith A Baggerly, Spiridon Tsavachidis, James C Lang, David E Schuller, Ralf Krahe.   

Abstract

BACKGROUND: Metastases are the primary cause of cancer treatment failure and death, yet metastatic mechanisms remain incompletely understood.
METHODS: We studied the molecular basis of head and neck cancer metastasis by transcriptionally profiling 70 samples from 27 patients-matching normal adjacent tissue, primary tumor, and cervical lymph node metastases.
RESULTS: We identified tumor-associated expression signatures common to both primary tumors and metastases. Use of matching metastases revealed an additional 46 dysregulated genes associated solely with head and neck cancer metastasis. However, despite being metastasis-specific in our sample set, these 46 genes are concordant with genes previously discovered in primary tumors that metastasized.
CONCLUSIONS: Although our data and related studies show that most of the metastatic potential appears to be inherent to the primary tumor, they are also consistent with the notion that a limited number of additional clonal changes are necessary to yield the final metastatic cell(s), albeit in a variable temporal order. Copyright (c) 2008 Wiley Periodicals, Inc. Head Neck 2008.

Entities:  

Mesh:

Year:  2008        PMID: 18642293      PMCID: PMC4136479          DOI: 10.1002/hed.20871

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  51 in total

1.  Epithelial-stromal interactions and tumor progression: meeting summary and future directions.

Authors:  L M Matrisian; G R Cunha; S Mohla
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 2.  Head and neck cancer.

Authors:  A Forastiere; W Koch; A Trotti; D Sidransky
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

Review 3.  The microenvironment of the tumour-host interface.

Authors:  L A Liotta; E C Kohn
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  A progression puzzle.

Authors:  René Bernards; Robert A Weinberg
Journal:  Nature       Date:  2002-08-22       Impact factor: 49.962

5.  Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma.

Authors:  Youyi Dong; Li Sui; Yasuo Watanabe; Katsuyoshi Sugimoto; Masaaki Tokuda
Journal:  Cancer Lett       Date:  2002-03-08       Impact factor: 8.679

Review 6.  Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies.

Authors:  Hiroyuki Tsuda; Kazunori Sekine; Ken-ichi Fujita; Masaaki Ligo
Journal:  Biochem Cell Biol       Date:  2002       Impact factor: 3.626

7.  Loss of MDA-7 expression with progression of melanoma.

Authors:  Julie A Ellerhorst; Victor G Prieto; Suhendan Ekmekcioglu; Lyle Broemeling; Sandra Yekell; Sunil Chada; Elizabeth A Grimm
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

8.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

9.  Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus.

Authors:  Ioannis D Kyriazanos; Mitsuo Tachibana; Dipok K Dhar; Muneaki Shibakita; Takashi Ono; Hitoshi Kohno; Naofumi Nagasue
Journal:  Oncol Rep       Date:  2002 May-Jun       Impact factor: 3.906

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  13 in total

1.  Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.

Authors:  Lei Huang; Odile David; Robert J Cabay; Klara Valyi-Nagy; Virgilia Macias; Rong Zhong; Barry Wenig; Lawrence Feldman; Ralph Weichselbaum; Michael T Spiotto
Journal:  Clin Cancer Res       Date:  2018-12-20       Impact factor: 12.531

Review 2.  Current potential and limitations of molecular diagnostic methods in head and neck cancer.

Authors:  Magdy E Mahfouz; Juan P Rodrigo; Robert P Takes; Mohamed N Elsheikh; Alessandra Rinaldo; Ruud H Brakenhoff; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06       Impact factor: 2.503

Review 3.  Prognostic biological features in neck dissection specimens.

Authors:  Julia A Woolgar; Asterios Triantafyllou; James S Lewis; Jennifer Hunt; Michelle D Williams; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-15       Impact factor: 2.503

Review 4.  Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?

Authors:  Luca Tonella; Marco Giannoccaro; Salvatore Alfieri; Silvana Canevari; Loris De Cecco
Journal:  Curr Treat Options Oncol       Date:  2017-05

5.  Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.

Authors:  Xin Feng; Tan Zhang; Jeff Chou; Liang Liu; Lance D Miller; Christopher A Sullivan; James D Browne
Journal:  Head Neck       Date:  2021-11-29       Impact factor: 3.147

6.  Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse.

Authors:  Christina S Kong; Hongbin Cao; Shirley Kwok; Catherine M Nguyen; Richard C Jordan; Veronica G Beaudry; Laura D Attardi; Quynh-Thu Le
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-01

7.  Prognostic significance of the tumour-adjacent tissue in head and neck cancers.

Authors:  Martina Raudenska; Marketa Sztalmachova; Jaromir Gumulec; Michaela Fojtu; Hana Polanska; Jan Balvan; Marek Feith; Hana Binkova; Zuzana Horakova; Rom Kostrica; Rene Kizek; Michal Masarik
Journal:  Tumour Biol       Date:  2015-07-14

8.  Single sample expression-anchored mechanisms predict survival in head and neck cancer.

Authors:  Xinan Yang; Kelly Regan; Yong Huang; Qingbei Zhang; Jianrong Li; Tanguy Y Seiwert; Ezra E W Cohen; H Rosie Xing; Yves A Lussier
Journal:  PLoS Comput Biol       Date:  2012-01-26       Impact factor: 4.475

9.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.

Authors:  Sidharth V Puram; Itay Tirosh; Anuraag S Parikh; Anoop P Patel; Keren Yizhak; Shawn Gillespie; Christopher Rodman; Christina L Luo; Edmund A Mroz; Kevin S Emerick; Daniel G Deschler; Mark A Varvares; Ravi Mylvaganam; Orit Rozenblatt-Rosen; James W Rocco; William C Faquin; Derrick T Lin; Aviv Regev; Bradley E Bernstein
Journal:  Cell       Date:  2017-11-30       Impact factor: 41.582

10.  Identification of ovarian cancer metastatic miRNAs.

Authors:  Souriya Vang; Hsin-Ta Wu; Andrew Fischer; Daniel H Miller; Shannon MacLaughlan; Elijah Douglass; Lauren Comisar; Margaret Steinhoff; Colin Collins; Peter J S Smith; Laurent Brard; Alexander S Brodsky
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.